Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …

Objective Hepatitis D virus (HDV) is a defective virus that completes its life cycle only with
hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of …

The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to
achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in …

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …

Background: The burden of surgical infections in low-and middle-income countries (LMICs)
remains poorly defined compared with high-income countries. Although there are common …

ABSTRACT In sub-Saharan Africa (SSA), chronic viral hepatitis B (HBV) affects more than
60 million people. Mother-to-child transmission is a major contributor to the ongoing HBV …

Background Hepatitis D virus (also known as hepatitis delta virus) can establish a persistent
infection in people with chronic hepatitis B, leading to accelerated progression of liver …

Hepatocellular carcinoma (HCC) is a cancer which occurs in liver and severity of this cancer
makes it the sixth most prevalent cancer and second leading cause of death among all …

Background: Stigma, poverty, and lack of knowledge present barriers to the diagnosis and
treatment of chronic infection, especially in resource-limited settings. Chronic Hepatitis B …

Chronic hepatitis B virus infection (HBV) continues to pose a serious global health threat in
many areas of the world, particularly in sub-Saharan Africa, the Western Pacific Region and …